MicroRNAs: Promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis

34Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer-related death worldwide. Distant metastasis is a major cause of mortality in CRC. MicroRNAs (miRNAs) are small non-coding RNA molecules involved in the post-transcriptional and translational regulation of gene expression. Many miRNAs are aberrantly expressed in cancer and influence tumor progression. Accumulating studies suggest that multiple miRNAs are actively involved in the CRC metastasis process. Thus, we aim to introduce the role of mi- RNAs in multi-steps of CRC metastasis, including cancer cell invasion, intravasation, circulation, extravasation, colonization, angiogenesis, and epithelial-mesenchymal transition (EMT). Moreover, we suggest the potential application of miRNAs as biomarkers for CRC patients with metastasis.

Cite

CITATION STYLE

APA

Hur, K. (2015). MicroRNAs: Promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis. BMB Reports. The Biochemical Society of the Republic of Korea. https://doi.org/10.5483/BMBRep.2015.48.4.007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free